Save time and get answers to complex questions with AI chat
Bivalirudin manufacturer?What is the difference between apixaban and apixaban accord?Mebendazole 100mg price?Dabrafenib and trametinib price?Chlorpheniramine cost?
See the DrugPatentWatch profile for Relugolix
Relugolix (an oral GnRH antagonist for advanced prostate cancer) – the patent landscape in a nutshell | Patent | Filing / Publication | Key Claims | Status (as of July 2026) | Notes | |--------|----------------------|------------|--------------------------|-------| | WO 2015/090586
Other Questions About Relugolix :